Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suicide and schizophrenia.

S G Siris1

  • 1Department of Psychiatry, Hillside Hospital Division of the North Shore, Long Island Jewish Health System and The Albert Einstein College of Medicine, New York, USA. siris@LIJ.edu

Journal of Psychopharmacology (Oxford, England)
|July 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical issues related to depression in schizophrenia: an international survey of psychiatrists.

Acta psychiatrica Scandinavica·2002
Same author

Depression in schizophrenia: recognition and management in the USA.

Schizophrenia research·2001
Same author

Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes.

Schizophrenia bulletin·2000
Same author

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.

The American journal of psychiatry·2000
Same author

Relationship of panic attacks to paranoia.

The American journal of psychiatry·1999
Same author

Clinical trials and tribulations: implementation processes in schizophrenia research outcome.

Psychiatry·1999
Same journal

Caution in interpreting value-related change after psilocybin: Comment on Kerr-Gaffney et al. (2026).

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Effects of antidepressants, anesthetics and sedatives/hypnotics on sleep-associated memory consolidation - A systematic review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mental resilience is not meaningfully associated with the frequency and severity of alcohol hangover.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

People with schizophrenia have higher rates of suicide. Depression is a key factor, and understanding its causes in schizophrenia is crucial for effective treatment and prevention strategies.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Schizophrenia is associated with significantly higher rates of suicide and suicide attempts compared to the general population.
  • An estimated 10% of individuals with schizophrenia die by suicide, with attempts occurring at two to five times this rate.
  • Numerous demographic, psychosocial, and clinical factors are linked to suicidality in schizophrenia.

Purpose of the Study:

  • To explore the complex relationship between depression and suicide in schizophrenia.
  • To review the differential diagnosis of depression in schizophrenia, identifying treatable causes.
  • To consider the role of pharmacological and psychosocial interventions in managing suicidality.

Main Methods:

  • Literature review focusing on depression as a correlate of suicide in schizophrenia.

Related Experiment Videos

  • Analysis of differential diagnoses for depressive states in schizophrenia.
  • Evaluation of treatment options, including atypical antipsychotics and psychosocial interventions.

    • Main Results:

    • Depressive symptoms and syndromes are common correlates of suicidality in schizophrenia.
    • Differential diagnoses for depression include disappointment reactions, psychotic prodromes, neuroleptic side effects, negative symptoms, and co-occurring depressive disorders.
    • Atypical antipsychotics and psychosocial interventions show potential benefits.

    Conclusions:

    • Accurate diagnosis of depression in schizophrenia is vital for effective suicide prevention.
    • Treatment strategies should address underlying causes of depression and incorporate both medication and psychosocial support.
    • Further research into optimal management of depression and suicidality in schizophrenia is warranted.